Expression of constitutively active cGMP-dependent protein kinase inhibits glucose-induced vascular smooth muscle cell proliferation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 6, 2009, Pages

  Wang, Shuxia ^a   Li, Yanzhang ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cell cycle; Cell proliferation; Glucose; Guanosine 5 cyclic monophosphate dependent protein kinase; Vascular smooth muscle cells

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLUCOSE; PROTEIN KINASE; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME MECHANISM; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CATALYTIC DOMAIN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GLUCOSE; HYPERGLYCEMIA; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RATS; RETINOBLASTOMA PROTEIN; TRANSFECTION;

EID: 72249105079     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00521.2009     Document Type: Article

References (51)

1. Anderson PG, Boerth NJ, Liu M, McNamara DB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb Vasc Biol 20: 2192-2197, 2000. (Pubitemid 30777773)
2. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 16: 815-820, 1996. (Pubitemid 26179371)
3. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34: 245-259, 1997.
4. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 98: 82-89, 1998.
5. Calkin AC, Forbes JM, Smith CM, Lassila M, Cooper ME, Jandeleit- Dahm KA, Allen TJ. Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler Thromb Vasc Biol 25: 1903-1909, 2005.
6. Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME, Jandeleit-Dahm KA. A Irbesartan but not amlodipine suppresses diabetes- associated atherosclerosis. Circulation 109: 1536-1542, 2004. (Pubitemid 38420183)
7. Cen B, Deguchi A, Weinstein IB. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. Cancer Res 68: 5355-5362, 2008.
8. Chan KC, Wang CJ, Ho HH, Chen HM, Huang CN. Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53. Pharmacol Res 58: 247-256, 2008.
9. Chiche JD, Schlutsmeyer SM, Bloch DB, de la Monte SM, Roberts JD Jr, Filippov G, Janssens SP, Rosenzweig A, Bloch KD. Adenovirusmediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem 273: 34263-34271, 1998. (Pubitemid 129758369)
10. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267: C1405-C1413, 1994. (Pubitemid 2163839)
11. Dey NB, Boerth NJ, Murphy-Ullrich JE, Chang PL, Prince CW, Lincoln TM. Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82: 139-146, 1998. (Pubitemid 28080096)
12. Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 33: 601-607, 2001. (Pubitemid 32215612)
13. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 75: 669-681, 1994.
14. Fukumoto S, Koyama H, Hosoi M, Yamakawa K, Tanaka S, Morii H, Nishizawa Y. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res 85: 985-991, 1999.
15. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44: S54-S64, 2001. (Pubitemid 32844113)
16. Hanada S, Terada Y, Inoshita S, Sasaki S, Lohmann SM, Smolenski A, Marumo F. Overexpression of protein kinase G using adenovirus inhibits cyclin E transcription and mesangial cell cycle. Am J Physiol Renal Physiol 280: F851-F859, 2001. (Pubitemid 32441261)
17. Hurst RT, Lee RW. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139: 824-834, 2003.
18. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E, Perrino C, Chieffo A, Pardo F, Chiariello M. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103: 2980-2986, 2001. (Pubitemid 32578138)
19. Jacob A, Smolenski A, Lohmann SM, Begum N. MKP-1 expression and stabilization and cGK Ialpha prevent diabetes- associated abnormalities in VSMC migration. Am J Physiol Cell Physiol 287: C1077-C1086, 2004. (Pubitemid 39238332)
20. Jacob T, Hingorani A, Ascher E. Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions. Angiology 26: 26, 2009.
21. Kanzaki T, Shiina R, Saito Y, Zardi L, Morisaki N. Transforming growth factor-beta receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats. Diabetologia 40: 383-391, 1997. (Pubitemid 27132608)
22. Ko YS, Yeh HI, Haw M, Dupont E, Kaba R, Plenz G, Robenek H, Severs NJ. Differential expression of connexin43 and desmin defines two subpopulations of medial smooth muscle cells in the human internal mammary artery. Arterioscler Thromb Vasc Biol 19: 1669-1680, 1999. (Pubitemid 29323825)
23. Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, Candido R, Cooper ME. Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol 24: 935-942, 2004.
24. Lee HS, Son SM, Kim YK, Hong KW, Kim CD. NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. Life Sci 72: 2719-2730, 2003.
25. Li SL, Reddy MA, Cai Q, Meng L, Yuan H, Lanting L, Natarajan R. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 55: 2611-2619, 2006. (Pubitemid 44871163)
26. Lincoln TM, Wu X, Sellak H, Dey N, Choi CS. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 11: 356-367, 2006. (Pubitemid 43253498)
27. Liu S, Ma X, Gong M, Shi L, Lincoln T, Wang S. Glucose downregulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 42: 852-863, 2007. (Pubitemid 46274174)
28. Morgan DO. Principles of CDK regulation. Nature 374: 131-134, 1995.
29. Mori S, Takemoto M, Yokote K, Asaumi S, Saito Y. Hyperglycemiainduced alteration of vascular smooth muscle phenotype. J Diabetes Complications 16: 65-68, 2002. (Pubitemid 34168504)
30. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 187: 552-560, 1992.
31. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S. Intensive diabetes therapy and carotid intimamedia thickness in type 1 diabetes mellitus. N Engl J Med 348: 2294-2303, 2003. (Pubitemid 36638103)
32. Onumah OE, Jules GE, Zhao Y, Zhou L, Yang H, Guo Z. Overexpression of catalase delays G(0)/G(1) to S phase transition during cell cycle progression in mouse aortic endothelial cells (Abstract). Free Radic Biol Med 30: 30, 2009.
33. Pandolfi A, Grilli A, Cilli C, Patruno A, Giaccari A, Di Silvestre S, De Lutiis MA, Pellegrini G, Capani F, Consoli A, Felaco M. Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. J Cell Physiol 196: 378-385, 2003. (Pubitemid 36775886)
34. Sherr CJ. Cancer cell cycles. Science 274: 1672-1677, 1996.
35. Sherr CJ. G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
36. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
37. Sinnaeve P, Chiche JD, Gillijns H, Van Pelt N, Wirthlin D, Van De Werf F, Collen D, Bloch KD, Janssens S. Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis. Circulation 105: 2911-2916, 2002. (Pubitemid 34666107)
38. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. Analysis and regulation of vasodilatorstimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273: 20029-20035, 1998. (Pubitemid 28377554)
39. Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 55: 901-910, 2006. (Pubitemid 44100162)
40. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1: 207-214, 1999.
41. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50: 851-860, 2001. (Pubitemid 32242644)
42. Tanner FC, Boehm M, Akyurek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101: 2022-2025, 2000. (Pubitemid 30233162)
43. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82: 396-403, 1998. (Pubitemid 28101197)
44. Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 247: 1-15, 2000. (Pubitemid 30201556)
45. Wang S, Wu X, Lincoln TM, Murphy-Ullrich JE. Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity. Diabetes 52: 2144-2150, 2003. (Pubitemid 36919810)
46. Watson PA, Nesterova A, Burant CF, Klemm DJ, Reusch JE. Diabetes- related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem 276: 46142-46150, 2001. (Pubitemid 37370865)
47. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
48. Wu YJ, Bond M, Sala-Newby GB, Newby AC. Altered S-phase kinaseassociated protein-2 levels are a major mediator of cyclic nucleotideinduced inhibition of vascular smooth muscle cell proliferation. Circ Res 98: 1141-1150, 2006. (Pubitemid 43948100)
49. Yasuda Y, Nakamura J, Hamada Y, Nakayama M, Chaya S, Naruse K, Nakashima E, Kato K, Kamiya H, Hotta N. Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells. Biochem Biophys Res Commun 281: 71-77, 2001. (Pubitemid 32924401)
50. Yu SM, Hung LM, Lin CC. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 95: 1269-1277, 1997.
51. Zanetti M, Barazzoni R, Stebel M, Roder E, Biolo G, Baralle FE, Cattin L, Guarnieri G. Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat. Atherosclerosis 181: 69-73, 2005. (Pubitemid 40804695)